Antisense oligodeoxyribonucleotide as to the growth factor midkine suppresses neointima formation induced by balloon injury

被引:18
作者
Hayashi, K
Banno, H
Kadomatsu, K
Takei, Y
Komori, K
Muramatsu, T
机构
[1] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Vasc Surg, Nagoya, Aichi, Japan
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 288卷 / 05期
关键词
molecular target; phosphorothioate; vascular restenosis;
D O I
10.1152/ajpheart.00555.2004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Restenosis is the major clinical problem of angioplasty. We have previously shown that neointima formation is strikingly suppressed in midkine (MK)- deficient mice. Neointima formation is restored if MK protein is administrated to the deficient mice. MK is a heparin- binding growth factor and implicated in the migration of inflammatory cells and vascular smooth muscle cells. Consistently, the suppression of neointima formation in the deficient mice is accompanied by suppression of recruitment of inflammatory cells into the vascular wall. Here, we evaluated the potential of MK antisense oligodeoxyribonucleotide (ODN) for the prevention of restenosis. We cloned the cDNA of rabbit MK, which showed a strongly conserved sequence in mammals. The balloon injury induced MK expression, with the maximum level occurring 7 - 14 days after angioplasty, in the rabbit carotid artery. Two antisense ODNs suppressed the production of MK in a rabbit kidney cell line, RK13 cells, one of which was then transfected into the arterial wall by means of lipofection immediately after balloon treatment. The antisense ODN suppressed MK induction in vivo and consequently suppressed neointima formation to 60% of the control level. These results suggest that MK is a candidate molecular target for the therapy for vascular restenosis.
引用
收藏
页码:H2203 / H2209
页数:7
相关论文
共 48 条
[21]   Inflammation and atherosclerosis [J].
Libby, P ;
Ridker, PM ;
Maseri, A .
CIRCULATION, 2002, 105 (09) :1135-1143
[22]   Bacterial DNA as immune cell activator [J].
Lipford, GB ;
Heeg, K ;
Wagner, H .
TRENDS IN MICROBIOLOGY, 1998, 6 (12) :496-500
[23]   A receptor-like protein-tyrosine phosphatase PTPζ/RPTPβ binds a heparin-binding growth factor midkine -: Involvement of arginine 78 of midkine in the high affinity binding to PTPζ [J].
Maeda, N ;
Ichihara-Tanaka, K ;
Kimura, T ;
Kadomatsu, K ;
Muramatsu, T ;
Noda, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (18) :12474-12479
[24]   Gene therapy for human bypass grafts [J].
Mangi, AA ;
Dzau, VJ .
ANNALS OF MEDICINE, 2001, 33 (03) :153-155
[25]   Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial [J].
Mann, MJ ;
Whittemore, AD ;
Donaldson, MC ;
Belkin, M ;
Conte, MS ;
Polak, JF ;
Orav, EJ ;
Ehsan, A ;
Dell'Acqua, G ;
Dzau, VJ .
LANCET, 1999, 354 (9189) :1493-1498
[26]   Synthetic oligonucleotides: The development of antisense therapeutics [J].
Monteith, DK ;
Levin, AA .
TOXICOLOGIC PATHOLOGY, 1999, 27 (01) :8-13
[27]   Essential role of monocyte chemoattractant protein-1 in development of restenotic changes (neointimal hyperplasia and constrictive remodeling) after balloon angioplasty in hypercholesterolemic rabbits [J].
Mori, E ;
Komori, K ;
Yamaoka, T ;
Tanii, M ;
Kataoka, C ;
Takeshita, A ;
Usui, M ;
Egashira, K ;
Sugimachi, K .
CIRCULATION, 2002, 105 (24) :2905-2910
[28]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[29]   LDL receptor-related protein as a component of the midkine receptor [J].
Muramatsu, H ;
Zou, K ;
Sakaguchi, N ;
Ikematsu, S ;
Sakuma, S ;
Muramatsu, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 270 (03) :936-941
[30]   Midkine and pleiotrophin: Two related proteins involved in development, survival, inflammation and tumorigenesis [J].
Muramatsu, T .
JOURNAL OF BIOCHEMISTRY, 2002, 132 (03) :359-371